The Valley Desk

NCT00094848 · Interventional trial

Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Overall registry status Completed

Phase 2

Conditions Lymphoma, Non-Hodgkin

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov